These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17132643)

  • 1. Axonal protection in multiple sclerosis--a particular need during remyelination?
    Smith KJ
    Brain; 2006 Dec; 129(Pt 12):3147-9. PubMed ID: 17132643
    [No Abstract]   [Full Text] [Related]  

  • 2. Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
    Waxman SG
    Nat Rev Neurosci; 2006 Dec; 7(12):932-41. PubMed ID: 17115075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regenerative capacity in multiple sclerosis].
    Lubetzki C
    Bull Acad Natl Med; 2008 Mar; 192(3):495-504; discussion 505-6. PubMed ID: 18819695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranes, myelin, and the pathophysiology of multiple sclerosis.
    Waxman SG
    N Engl J Med; 1982 Jun; 306(25):1529-33. PubMed ID: 7043271
    [No Abstract]   [Full Text] [Related]  

  • 5. Remyelination protects axons from demyelination-associated axon degeneration.
    Irvine KA; Blakemore WF
    Brain; 2008 Jun; 131(Pt 6):1464-77. PubMed ID: 18490361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to the development of pharmacological interventions in multiple sclerosis.
    Davis FA; Schauf CL
    Adv Neurol; 1981; 31():505-10. PubMed ID: 6275674
    [No Abstract]   [Full Text] [Related]  

  • 7. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.
    Coman I; Aigrot MS; Seilhean D; Reynolds R; Girault JA; Zalc B; Lubetzki C
    Brain; 2006 Dec; 129(Pt 12):3186-95. PubMed ID: 16766541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sodium channels and multiple sclerosis].
    Colotto M; Danese C
    Clin Ter; 2004 Jun; 155(6):245-8. PubMed ID: 15560285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The remyelination phenomenon in multiple sclerosis].
    Lubetzki C
    Bull Acad Natl Med; 2003; 187(4):699-707; discussion 707-10. PubMed ID: 14556477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remyelination is extensive in a subset of multiple sclerosis patients.
    Patrikios P; Stadelmann C; Kutzelnigg A; Rauschka H; Schmidbauer M; Laursen H; Sorensen PS; Brück W; Lucchinetti C; Lassmann H
    Brain; 2006 Dec; 129(Pt 12):3165-72. PubMed ID: 16921173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium channels as molecular targets in multiple sclerosis.
    Waxman SG
    J Rehabil Res Dev; 2002; 39(2):233-42. PubMed ID: 12051467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
    Lo AC; Black JA; Waxman SG
    Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the role of axonal ion channels in multiple sclerosis?
    Correale J; Marrodan M; Benarroch EE
    Neurology; 2020 Jul; 95(3):120-123. PubMed ID: 32482838
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status.
    Waxman SG
    Nat Clin Pract Neurol; 2008 Mar; 4(3):159-69. PubMed ID: 18227822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: Mitochondria and disease progression in multiple sclerosis.
    Mahad D; Lassmann H; Turnbull D
    Neuropathol Appl Neurobiol; 2008 Dec; 34(6):577-89. PubMed ID: 19076696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical mechanisms of impulse conduction in demyelinated axons.
    Waxman SG
    Adv Neurol; 1988; 47():185-213. PubMed ID: 2449805
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of demyelination.
    Rasminsky M
    Ann N Y Acad Sci; 1984; 436():68-85. PubMed ID: 6099708
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of axon-glial injury of the optic nerve.
    Compston A
    Eye (Lond); 2004 Nov; 18(11):1182-7. PubMed ID: 15534604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium channel blockers and axonal protection in neuroinflammatory disease.
    Waxman SG
    Brain; 2005 Jan; 128(Pt 1):5-6. PubMed ID: 15596795
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicopathological correlations in multiple sclerosis and related diseases.
    Waxman SG
    Adv Neurol; 1981; 31():169-82. PubMed ID: 7325041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.